DCPH - Deciphera Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - DCPH (1654151)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
46 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-05-11
DCPHKelly Thomas PatrickCFOS - Sale+OE$55.19-12,0007,040-63%-$662,240
D
2020-04-28
DCPHTaylor Michael DouglasDirS - Sale+OE$56.90-25,0000-100%-$1,422,490
D
2020-04-17
DCPHTaylor Michael DouglasDirS - Sale+OE$46.67-23,8920-100%-$1,115,150
D
2020-04-14
DCPHTaylor Michael DouglasDirS - Sale+OE$46.71-1,1080-100%-$51,753
D
2020-04-09
DCPHBristol James ArthurDirS - Sale+OE$43.83-23,5420-100%-$1,031,840
D
2020-04-01
DCPHTaylor Michael DouglasDirS - Sale+OE$37.57-75,0000-100%-$2,817,558
D
2020-01-24
DCPHAllen Patricia LDirS - Sale+OE$66.13-25,0000-100%-$1,653,325
D
2020-01-22
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale+OE$67.18-26,99917,000-61%-$1,813,709
DM
2020-01-15
DCPHMorl Christopher JohnChief Business OfficerS - Sale+OE$65.27-15,0340-100%-$981,205
DM
2020-01-07
DCPHMorl Christopher JohnChief Business OfficerS - Sale+OE$60.10-13,9310-100%-$837,308
DM
2020-01-02
DCPHTaylor Michael DouglasDirS - Sale+OE$57.71-125,0000-100%-$7,214,035
D
2020-01-02
DCPHMorl Christopher JohnChief Business OfficerS - Sale+OE$58.55-16,1370-100%-$944,872
DM
2020-01-02
DCPHKelly Thomas PatrickCFOS - Sale+OE$57.65-12,0000-100%-$691,741
DM
2020-01-02
DCPHBristol James ArthurDirS - Sale+OE$57.67-23,5420-100%-$1,357,663
D
2019-12-23
DCPHKelly Thomas PatrickCFOS - Sale+OE$68.21-40,0000-100%-$2,728,368
2019-12-12
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale$60.00-31,029115,520-21%-$1,861,740
D
2019-12-12
DCPHMorl Christopher JohnChief Business OfficerS - Sale+OE$60.00-15,0340-100%-$902,040
DM
2019-12-09
DCPHMorl Christopher JohnChief Business OfficerS - Sale+OE$55.00-15,0340-100%-$826,870
DM
2019-12-09
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale+OE$55.00-152,927146,549-51%-$8,410,985
D
2019-12-03
DCPHMorl Christopher JohnChief Business OfficerS - Sale+OE$50.00-15,0340-100%-$751,763
DM
2019-11-08
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale+OE$48.01-152,927146,549-51%-$7,342,486
D
2019-11-01
DCPHTaylor Michael DouglasDirS - Sale+OE$45.02-7,5000-100%-$337,646
D
2019-11-01
DCPHBristol James ArthurDirS - Sale+OE$45.07-25,0000-100%-$1,126,823
D
2019-10-28
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale+OE$40.00-29,820146,549-17%-$1,192,800
D
2019-10-28
DCPHKelly Thomas PatrickCFOS - Sale+OE$40.00-3,7500-100%-$150,010
2019-09-19
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale$35.56-3,00017,000-15%-$106,688
D
2019-09-11
DCPHKelly Thomas PatrickCFOS - Sale+OE$34.97-11,2500-100%-$393,440
D
2019-09-11
DCPHTaylor Michael DouglasDirS - Sale+OE$34.97-22,5000-100%-$786,832
D
2019-09-03
DCPHTaylor Michael DouglasDirS - Sale+OE$36.26-7,5000-100%-$271,975
M
2019-08-15
DCPHNew Leaf Venture Management Iii, L.L.C.10%S - Sale$36.42-350,0001,963,258-15%-$12,748,132
D
2019-08-13
DCPHTaylor Michael DouglasDirS - Sale+OE$40.77-22,5000-100%-$917,342
D
2019-08-13
DCPHKelly Thomas PatrickCFOS - Sale+OE$41.27-11,2500-100%-$464,255
D
2019-08-13
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale+OE$40.92-148,107146,549-50%-$6,060,755
D
2019-08-13
DCPHBristol James ArthurDirS - Sale+OE$39.97-25,0000-100%-$999,365
D
2019-06-19
DCPHKelly Thomas PatrickCFOS - Sale+OE$25.00-1770-100%-$4,425
D
2019-06-03
DCPHKelly Thomas PatrickCFOS - Sale+OE$25.20-2,1000-100%-$52,927
DM
2019-05-21
DCPHKelly Thomas PatrickCFOS - Sale+OE$25.06-1,4730-100%-$36,919
D
2019-05-01
DCPHKelly Thomas PatrickCFOS - Sale+OE$22.93-13,5000-100%-$309,524
D
2019-02-19
DCPHKelly Thomas PatrickCFOS - Sale+OE$30.00-1,5000-100%-$45,000
DM
2019-02-14
DCPHBristol James ArthurDirS - Sale+OE$28.04-18,8830-100%-$529,446
DM
2019-02-14
DCPHTaylor Michael DouglasPres, CEOS - Sale+OE$28.85-9,4310-100%-$272,106
D
2019-02-05
DCPHBristol James ArthurDirS - Sale+OE$28.02-2,5950-100%-$72,704
D
2019-02-05
DCPHTaylor Michael DouglasPres, CEOS - Sale+OE$28.01-1,7000-100%-$47,611
D
2019-01-16
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale+OE$26.00-152,629147,049-51%-$3,968,354
D
2019-01-11
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale+OE$26.00-300147,0490%-$7,800
D
2019-01-07
DCPHKelly Thomas PatrickCFOS - Sale+OE$25.18-5,0000-100%-$125,900
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top